{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:16:59Z","timestamp":1791314219236,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijcard.2013.05.063","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T20:45:45Z","timestamp":1371242745000},"page":"3527-3531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy"],"prefix":"10.1016","volume":"168","author":[{"given":"Jochen","family":"Springer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Tschirner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.05.063_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0010","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","article-title":"Cachexia: prevalence and impact in medicine","volume":"11","author":"Tan","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08037050310025735","article-title":"Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer","volume":"13","author":"Hammarsten","year":"2004","journal-title":"Blood Press"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpainsymman.2005.11.014","article-title":"Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients","volume":"31","author":"Shin","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.08.033","article-title":"Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice","volume":"621","author":"Tan","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cardfail.2008.06.006","article-title":"Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice","volume":"14","author":"Xu","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0035","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2013.05.063_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2010.10.028","article-title":"Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters","volume":"156","author":"Herrmann","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0045","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0055","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1016\/S0021-9258(19)52512-1","article-title":"Studies on the oxidative half-reaction of xanthine oxidase","volume":"256","author":"Hille","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0060","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.27494","article-title":"Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia","volume":"131","author":"Springer","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0070","first-page":"347","article-title":"Cardiac alterations in cancer-induced cachexia in mice","volume":"37","author":"Tian","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0075","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","article-title":"Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner","volume":"71","author":"Cosper","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13539-011-0029-3","article-title":"IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia","volume":"2","author":"Schmidt","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2008.06.094","article-title":"No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure","volume":"137","author":"Akashi","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2188\/jea.10.403","article-title":"Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers","volume":"10","author":"Tomita","year":"2000","journal-title":"J Epidemiol"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0100","first-page":"209","article-title":"The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting","volume":"3","author":"Tisdale","year":"2005","journal-title":"J Support Oncol"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/hr.2010.201","article-title":"Reactive oxygen species and vascular biology: implications in human hypertension","volume":"34","author":"Touyz","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfp042","article-title":"Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure","volume":"11","author":"Bergamini","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0115","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/0008-5472.CAN-05-3364","article-title":"Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells","volume":"66","author":"Griguer","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijcard.2013.05.063_bb0120","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","article-title":"Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313009911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313009911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T06:37:20Z","timestamp":1645771040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313009911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0167527313009911"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.05.063","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}